Representative publications in 2023

2023-12-29

Ningshao Xia：Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

2023-12-28

Ningshao Xia：Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

2023-11-30

Ningshao Xia:Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection.

2023-11-22

Ningshao Xia: Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

2023-09-22

Ningshao Xia: Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

2023-09-22

Hwan-Ching Tai：Wood cellulose microfibrils have a 24-chain core-shell nanostructure in seed plants

2023-06-23

Ningshao Xia:Structure and proposed DNA delivery mechanism of a marine roseophage

2023-06-19

Ningshao Xia:Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

2023-05-31

Ningshao Xia:Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.

2023-05-30